Industry News
Cutler joins CSIRO board
Former Industry, Research and Development Board chairman Dr Terry Cutler has been named as the fourth new appointee to the CSIRO board in the last two months. [ + ]
Starpharma gains new US patent approval
Nanotechnology drug developer Starpharma Pooled Development today announced it had gained approval for a United States patent over its dendrimer-based anti-cancer products. [ + ]
Biophotonics emerges as new force in Australian science
Bolstered by rising interest in the fusion of optics and biology, Australia's biophotonics community is lifting its game. [ + ]
Human-derived feeder cells used to grow human stem cells
Researchers have for the first time successfully grown human stem cells without exposure to mouse feeder cells. [ + ]
Australian technology helping bust New York smog
American researchers investigating the nature of air pollution in New York have chosen to utilise the international reputation and expertise of the Australian Nuclear Science and Technology Organisation (ANSTO) to analyse their samples.
[ + ]Nanotechnology keeps transplant organs in prime condition
A monitoring system that ensures transplant organs arrive in perfect condition for life-saving surgery has just been put on show by scientists in the United Kingdom.
[ + ]Prima applies for animal model patent
Inflammatory diseases researcher Arthron has lodged a patent application over an animal model of arthritis with which to test potential new treatments. [ + ]
pSivida rated 'speculative buy'
Brokers have rated biomaterials platform technology group pSivida a speculative buy following a recent joint venture with Singapore General Hospital. [ + ]
Iatia teams with Sydney Uni in new imaging facility
Melbourne high-tech imaging specialist Iatia has established a computer-based imaging facility at the University of Sydney's Key Centre for Microscopy and Microanalysis. [ + ]
Former opal miner Benitec opens for biotech business
Queensland company Benitec has finally begun trading on the Australian Stock Exchange after completing a backdoor listing through Queensland Opals. [ + ]
NZ: post-election, GM hangs in the balance
The post-election future of genetic modification in New Zealand hangs in the balance with the Labour Party still to determine the structure of its government. [ + ]
NIH backs down from IP grab
The US National Institutes of Health will defer implementing a policy that would allow it to limit ownership of patent rights and IP developed by NIH-funded Australian researchers. [ + ]
de Kretser returns as Monash IR&D director
Reproductive biologist Prof David de Kretser has returned to the director's role at the Monash Institute of Reproduction and Development. [ + ]
Intelligent Island appoints Centre of Excellence interim CEO
Tasmania's nascent Centre of Excellence for Bioinformatics has ended a national hunt for a chief executive by appointing a bioindustry executive with strong business strategy skills. [ + ]
BioStart money confirmed for Mimetica
Brisbane drug design company Mimetica is the first recipient of funds from Queensland's $6 million BioStart pre-seed fund, as foreshadowed by Australian Biotechnology News in June. [ + ]
